MALVERN, Pa.--(BUSINESS WIRE)--DSG, Inc., a global leader of eClinical software solutions and services for the life sciences industry has successfully launched a COVID-19 study with PhaseBio ...
Signant's leadership team selected DSG based on an extensive diligence of their solution suite, recognizing the opportunities inherent in its key characteristics, including: (1) ease of use – where ...
MALVERN, Pa.--(BUSINESS WIRE)--Human Genome Sciences (HGS: NASDAQ: HGSI) announced that BENLYSTA TM met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results